Literature DB >> 20215540

Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts.

Kimberly Walter1, Noriyuki Omura, Seung-Mo Hong, Margaret Griffith, Audrey Vincent, Michael Borges, Michael Goggins.   

Abstract

PURPOSE: Accumulating evidence suggests that cancer-associated stromal fibroblasts (CAF) contribute to tumor growth by actively communicating with cancer cells. Our aim is to identify signaling pathways involved in tumor-stromal cell interactions in human pancreatic cancer. EXPERIMENTAL
DESIGN: We established primary fibroblast cultures from human pancreatic adenocarcinomas and nonneoplastic pancreas tissues. To identify differentially expressed genes in CAFs, we did gene expression profiling of human pancreatic CAFs and nonneoplastic pancreatic fibroblasts.
RESULTS: The Hedgehog receptor Smoothened (SMO) was upregulated in CAFs relative to control fibroblasts. CAFs expressing SMO could transduce the Sonic hedgehog signal to activate Gli1 expression, and small interfering RNA knockdown of SMO blocked the induction of Gli1 in these cells. Stromal fibroblasts of human primary pancreatic adenocarcinomas overexpressed Smo compared with normal pancreatic fibroblasts.
CONCLUSIONS: These findings implicate overexpression of Smo as a mechanism for the activation of Hedgehog signaling in human pancreatic CAFs and suggest that stromal cells may be a therapeutic target for Smo antagonists in pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215540      PMCID: PMC2846609          DOI: 10.1158/1078-0432.CCR-09-1913

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  37 in total

1.  Human homolog of patched, a candidate gene for the basal cell nevus syndrome.

Authors:  R L Johnson; A L Rothman; J Xie; L V Goodrich; J W Bare; J M Bonifas; A G Quinn; R M Myers; D R Cox; E H Epstein; M P Scott
Journal:  Science       Date:  1996-06-14       Impact factor: 47.728

2.  Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.

Authors:  J Reifenberger; M Wolter; R G Weber; M Megahed; T Ruzicka; P Lichter; G Reifenberger
Journal:  Cancer Res       Date:  1998-05-01       Impact factor: 12.701

Review 3.  Stromal fibroblasts in cancer: a novel tumor-promoting cell type.

Authors:  Akira Orimo; Robert A Weinberg
Journal:  Cell Cycle       Date:  2006-08-01       Impact factor: 4.534

4.  ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression.

Authors:  L Peduto; V E Reuter; A Sehara-Fujisawa; D R Shaffer; H I Scher; C P Blobel
Journal:  Oncogene       Date:  2006-04-10       Impact factor: 9.867

5.  Activating Smoothened mutations in sporadic basal-cell carcinoma.

Authors:  J Xie; M Murone; S M Luoh; A Ryan; Q Gu; C Zhang; J M Bonifas; C W Lam; M Hynes; A Goddard; A Rosenthal; E H Epstein; F J de Sauvage
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

6.  Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.

Authors:  C M Counter; W C Hahn; W Wei; S D Caddle; R L Beijersbergen; P M Lansdorp; J M Sedivy; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Periostin deposition in the stroma of invasive and intraductal neoplasms of the pancreas.

Authors:  Noriyoshi Fukushima; Yoshinao Kikuchi; Takashi Nishiyama; Akira Kudo; Masashi Fukayama
Journal:  Mod Pathol       Date:  2008-05-16       Impact factor: 7.842

8.  Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.

Authors:  H Hahn; C Wicking; P G Zaphiropoulous; M R Gailani; S Shanley; A Chidambaram; I Vorechovsky; E Holmberg; A B Unden; S Gillies; K Negus; I Smyth; C Pressman; D J Leffell; B Gerrard; A M Goldstein; M Dean; R Toftgard; G Chenevix-Trench; B Wainwright; A E Bale
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

9.  Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma.

Authors:  N Liu; T Furukawa; M Kobari; M S Tsao
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

10.  Smoothened-mediated Hedgehog signalling is required for the maintenance of the anterior-posterior lineage restriction in the developing wing of Drosophila.

Authors:  S S Blair; A Ralston
Journal:  Development       Date:  1997-10       Impact factor: 6.868

View more
  85 in total

1.  Aberrant signaling pathways in pancreatic cancer: a two compartment view.

Authors:  Angela L McCleary-Wheeler; Robert McWilliams; Martin E Fernandez-Zapico
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 2.  The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.

Authors:  Alphonse E Sirica
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-29       Impact factor: 46.802

3.  Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins.

Authors:  Noriyuki Omura; Margaret Griffith; Audrey Vincent; Ang Li; Seung-Mo Hong; Kimberly Walter; Michael Borges; Michael Goggins
Journal:  Mol Cancer Res       Date:  2010-06-08       Impact factor: 5.852

Review 4.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

5.  Immunohistochemical evidence of the prognostic value of hedgehog pathway components in primary gallbladder carcinoma.

Authors:  Jinmao Li; Tao Wu; Jianguo Lu; Yizhan Cao; Nuan Song; Tao Yang; Rui Dong; Yuan Yang; Li Zang; Xilin Du; Shengzhi Wang
Journal:  Surg Today       Date:  2012-03-10       Impact factor: 2.549

Review 6.  Novel therapeutic targets for pancreatic cancer.

Authors:  Shing-Chun Tang; Yang-Chao Chen
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

7.  Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment.

Authors:  Agnieszka A Rucki; Qian Xiao; Stephen Muth; Jianlin Chen; Xu Che; Jennifer Kleponis; Rajni Sharma; Robert A Anders; Elizabeth M Jaffee; Lei Zheng
Journal:  Mol Cancer Ther       Date:  2017-09-01       Impact factor: 6.261

Review 8.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

9.  Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.

Authors:  Matija Snuderl; Ana Batista; Nathaniel D Kirkpatrick; Carmen Ruiz de Almodovar; Lars Riedemann; Elisa C Walsh; Rachel Anolik; Yuhui Huang; John D Martin; Walid Kamoun; Ellen Knevels; Thomas Schmidt; Christian T Farrar; Benjamin J Vakoc; Nishant Mohan; Euiheon Chung; Sylvie Roberge; Teresa Peterson; Carlos Bais; Boryana H Zhelyazkova; Stephen Yip; Martin Hasselblatt; Claudia Rossig; Elisabeth Niemeyer; Napoleone Ferrara; Michael Klagsbrun; Dan G Duda; Dai Fukumura; Lei Xu; Peter Carmeliet; Rakesh K Jain
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

Review 10.  Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review.

Authors:  Eckhard Klieser; Stefan Swierczynski; Christian Mayr; Tarkan Jäger; Johanna Schmidt; Daniel Neureiter; Tobias Kiesslich; Romana Illig
Journal:  World J Gastrointest Pathophysiol       Date:  2016-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.